However, this study, which represents routine clinical practice in Korea and was performed before the publication of the RACING trial, identified an increasing trend of favoring moderate-intensity statin with ezetimibe combination therapy over high-intensity statin monotherapy in patients undergoing percutaneous coronary intervention.
← all excerpts
Comparative effectiveness of moderate-intensity statin with ezetimibe therapy versus high-intensity statin monotherapy in patients with acute coronary syndrome: a nationwide cohort study.
1
—
—